Föreläsningar och seminarier OnkPat Friday Seminar: CAR T Cell Therapy: From Lymphoma to Autoimmunity
Välkommen till OnkPat Friday Seminar, den här gången med Dimitrios Mougiakakos, professor vid Otto-von-Guericke Universität i Magdeburg.
Värd: Maurice Michel, institutionen för onkologi-patologi
Du kan läsa mer om seminariet och Dimitrios på den engelska sidan.
Senaste publikationer
BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia.
Duque-Afonso J, Rummelt C, Förster K, Zeiser R, Mougiakakos D
Lancet 2026 Jan;407(10527):489-491
Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis.
Schreiber S, Al-Dubai M, Vielhaber S, Lefterova L, Dietrich S, Ruck T, Meuth S, Walther D, Mougiakakos D
Mol Ther 2025 Sep;33(9):4130-4134
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells.
Trautmann-Grill K, von Bonin M, Georgi A, Middeke JM, Böttcher M, Meyer O, Borie D, Bornhäuser M, Mikusko M, Wolleschak D, Mougiakakos D
Lancet 2025 Jan;405(10472):25-28
CAR T cells in autoimmunity: game changer or stepping stone?
Mougiakakos D, Meyer EH, Schett G
Blood 2025 Apr;145(17):1841-1849
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis.
Haghikia A, Hegelmaier T, Wolleschak D, Böttcher M, Pappa V, Motte J, Borie D, Gold R, Feist E, Schett G, Mougiakakos D
Ann Rheum Dis 2024 Oct;83(11):1597-1598
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases.
Haghikia A, Schett G, Mougiakakos D
Lancet Neurol 2024 Jun;23(6):615-624
CAR T-cell therapy in autoimmune diseases.
Schett G, Mackensen A, Mougiakakos D
Lancet 2023 Nov;402(10416):2034-2044
Anti-CD19 CAR T cells for refractory myasthenia gravis.
Haghikia A, Hegelmaier T, Wolleschak D, Böttcher M, Desel C, Borie D, Motte J, Schett G, Schroers R, Gold R, Mougiakakos D
Lancet Neurol 2023 Dec;22(12):1104-1105
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, Manger B, Mackensen A, Schett G
N Engl J Med 2021 Aug;385(6):567-569